Targeted Regional Injection of Biocomposite Microspheres Alters Post–Myocardial Infarction Remodeling and Matrix Proteolytic Pathways
Author(s) -
Jennifer A. Dixon,
Robert C. Gorman,
Robert E. Stroud,
Rupak Mukherjee,
Evan Meyer,
Nathaniel L. Baker,
Masato Morita,
Hirotsugu Hamamoto,
Liam P. Ryan,
Joseph H. Gorman,
Francis G. Spinale
Publication year - 2011
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.111.035774
Subject(s) - medicine , myocardial infarction , matrix metalloproteinase , saline , ventricular remodeling , microsphere , cardiology , endocrinology , chemical engineering , engineering
Although localized delivery of biocomposite materials, such as calcium hydroxyapatite (CHAM), have been demonstrated to potentially attenuate adverse left ventricular (LV) remodeling after myocardial infarction (MI), the underlying biological mechanisms for this effect remain unclear. This study tested the hypothesis that targeted CHAM injections would alter proteolytic pathways (matrix metalloproteinases [MMPs] and tissue inhibitors of MMPs [TIMPs]) and would be associated with parameters of post-MI LV remodeling.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom